Revenue and Operating Income Grew Year-Over-Year by 68% and 28%, Respectively PLAINVIEW, NY / ACCESSWIRE / August 15, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months ended June 30, 2016. “We are pleased to report that the Company recorded $18.2 million of total revenue during the...
Read More

Management to Hold Investor Conference Call on August 15, 2016 at 11:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / August 8, 2016 / Vasomedical, Inc. (PINKSHEETS:VASO) announced today that it will release its financial results for the three months ended June 30, 2016 on Monday, August 15, 2016, before market open. The Company will host...
Read More

Revenue Grew 135% Year-over-Year; Adjusted EBITDA Improved to $0.71 Million PLAINVIEW, NY / ACCESSWIRE / May 13, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months ended March 31, 2016. “We are excited to report that during the first quarter 2016, the Company recorded $17.5 million of...
Read More

Management to Hold Investor Conference Call on May 13, 2016 at 10:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / May 6, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months ended March 31, 2016 on Friday, May 13, 2016, before market open. The Company will...
Read More

Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue PLAINVIEW, NY / ACCESSWIRE / March 29, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months and year ended December 31, 2015. “With a 63% year-over-year growth in annual revenue...
Read More